Amrita Aranake-Chrisinger, MD, MSCI, receives FAER fellowship award
Feb 03, 2017
Amrita Aranake-Chrisinger, MD, MSCI, receives highly competitive $75,000 Foundation for Anesthesia Education and Research (FAER) fellowship award.
Amrita Aranake-Chrisinger, MD, MSCI, is the recipient of a highly competitive $75,000 Foundation for Anesthesia Education and Research (FAER) fellowship award. She will begin her project “The association between postoperative delirium and intermediate-term postoperative cognitive outcomes” in July 2017.
Postoperative delirium is a common complication in patients older than sixty, characterized by a fluctuating course of altered consciousness, disordered thinking and inattention. In preliminary research, postoperative delirium specifically has been associated with several adverse intermediate term outcomes, including persistent cognitive impairment and decreased quality of life. However, it is unclear whether these associations are independent of potentially confounding factors, such as patient co-morbid conditions, postoperative complications, and frailty. The objective of this project is to determine whether postoperative delirium is an independent risk factor for persistent impairments in attention and executive function. Over the next 30 years, the population of older adults is projected to double; many will undergo elective surgery with the hope of overall improvement in health and quality of life. By identifying perioperative factors that influence patient cognition and quality of life one year after surgery, the results of this study will contribute valuable insights into intermediate term patient-centered outcomes in older adults following major surgery.
Dr. Aranake-Chrisinger is a research track resident in the Scholar program in the Department of Anesthesiology. Her research interest is in the area of neurological outcomes after surgery. Her ultimate goal is to become a clinical trialist. In conjunction with receiving an MD from Washington University School of Medicine in 2012, Dr. Aranake received an MS in Clinical Investigation, and prior to that a BA in Molecular Biology and Biochemistry from Rutgers University in 2008.
This story has been viewed 60836 times